Missing/wrong data?
Log in to edit
MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial
scientific article published on 13 June 2018
Author/s
author: Mark Smithers, Evgeny V Levchenko, Piotr Rutkowski, Alessandro Testori, Hans C. van Houwelingen, Axel Hauschild, Wim H J Kruit, Jelle Goeman
Work details
Publication date
June 13, 2018
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.